Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors-Reference-Cited by-同舟云学术

Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors

Published:2021-01 Issue: Volume:296 Page:100133
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jones Ben^ORCID,McGlone Emma Rose,Fang Zijian,Pickford Phil,Corrêa Ivan R.,Oishi Atsuro,Jockers Ralf,Inoue Asuka,Kumar Sunil,Görlitz Frederik,Dunsby Chris,French Paul M.W.,Rutter Guy A.,Tan Tricia,Tomas Alejandra,Bloom Stephen R.

Funder

UKRI | Medical Research Council

Academy of Medical Sciences

Society for Endocrinology

British Society for Neuroendocrinology

European Association for the Study of Diabetes

UKRI | Engineering and Physical Sciences Research Council

Diabetes UK

Wellcome

Innovative Medicines Initiative

FP7 Health

Fondation de la Recherche Médicale

Agence Nationale de la Recherche

Institut National de la Santé et de la Recherche Médicale

Centre National de la Recherche Scientifique

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference82 articles.

1. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents;Finan;Nat. Med.,2015

2. Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia;Tan;Diabetes,2013

3. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions;Nauck;Lancet Diabetes Endocrinol.,2016

4. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells;Dyachok;Nature,2006

5. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein);Benovic;Proc. Natl. Acad. Sci. U. S. A.,1987

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

2. GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology;Peptides;2024-07

3. Reduced incretin receptor trafficking upon activation enhances glycemic control and reverses obesity in diet-induced obese mice;American Journal of Physiology-Cell Physiology;2024-07-01

4. Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge;British Journal of Pharmacology;2024-07

5. Molecular mapping and functional validation of GLP-1R cholesterol binding sites in pancreatic beta cells;2024-06-24